EphB1-IN-2 is a mutant-selective kinase inhibitor of ABL and FGFR4 , with an IC 50 of 14 nM against ABL G321C mutant and 163 nM against FGFR4 G556C mutant . EphB1-IN-2 shows selectively over wild-type ABL and FGFR4 .
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Others | Products > Signaling Pathways > FGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.